Woodrow Adam 4
4 · Paratek Pharmaceuticals, Inc. · Filed Aug 10, 2022
Insider Transaction Report
Form 4
Woodrow Adam
VP & Chief Commercial Officer
Transactions
- Award
Common Stock
2022-08-08+71,591→ 635,170 total
Footnotes (1)
- [F1]Represents performance-based restricted stock units granted on February 19, 2020 to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan that vested on August 8, 2022.